AXON
Price
$795.48
Change
+$20.93 (+2.70%)
Updated
Jul 3 closing price
Capitalization
61.93B
37 days until earnings call
FGEN
Price
$5.61
Change
+$0.36 (+6.86%)
Updated
Jul 3 closing price
Capitalization
22.67M
36 days until earnings call
Interact to see
Advertisement

AXON vs FGEN

Header iconAXON vs FGEN Comparison
Open Charts AXON vs FGENBanner chart's image
Axon Enterprise
Price$795.48
Change+$20.93 (+2.70%)
Volume$268.67K
Capitalization61.93B
FibroGen
Price$5.61
Change+$0.36 (+6.86%)
Volume$33.07K
Capitalization22.67M
AXON vs FGEN Comparison Chart in %
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. FGEN commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and FGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AXON: $795.48 vs. FGEN: $5.61)
Brand notoriety: AXON and FGEN are both not notable
AXON represents the Aerospace & Defense, while FGEN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 47% vs. FGEN: 81%
Market capitalization -- AXON: $61.93B vs. FGEN: $22.67M
AXON [@Aerospace & Defense] is valued at $61.93B. FGEN’s [@Biotechnology] market capitalization is $22.67M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $263.27B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $20.16B. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 3 FA rating(s) are green whileFGEN’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 3 green, 2 red.
  • FGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than FGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 3 TA indicator(s) are bullish while FGEN’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 3 bullish, 5 bearish.
  • FGEN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FGEN is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -1.05% price change this week, while FGEN (@Biotechnology) price change was +5.85% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.15%. For the same industry, the average monthly price growth was +9.89%, and the average quarterly price growth was +43.99%.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

AXON is expected to report earnings on Nov 06, 2025.

FGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Aerospace & Defense (+1.15% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($61.9B) has a higher market cap than FGEN($22.7M). AXON YTD gains are higher at: 33.847 vs. FGEN (-57.620). AXON has higher annual earnings (EBITDA): 398M vs. FGEN (-110.48M). AXON has more cash in the bank: 2.37B vs. FGEN (1.73M). FGEN has less debt than AXON: FGEN (73.4M) vs AXON (2.05B). AXON has higher revenues than FGEN: AXON (2.23B) vs FGEN (7M).
AXONFGENAXON / FGEN
Capitalization61.9B22.7M272,687%
EBITDA398M-110.48M-360%
Gain YTD33.847-57.620-59%
P/E Ratio191.68N/A-
Revenue2.23B7M31,818%
Total Cash2.37B1.73M136,821%
Total Debt2.05B73.4M2,789%
FUNDAMENTALS RATINGS
AXON vs FGEN: Fundamental Ratings
AXON
FGEN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
7100
SMR RATING
1..100
54100
PRICE GROWTH RATING
1..100
293
P/E GROWTH RATING
1..100
856
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FGEN's Valuation (93) in the Biotechnology industry is in the same range as AXON (99). This means that FGEN’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (7) in the Biotechnology industry is significantly better than the same rating for FGEN (100). This means that AXON’s stock grew significantly faster than FGEN’s over the last 12 months.

AXON's SMR Rating (54) in the Biotechnology industry is somewhat better than the same rating for FGEN (100). This means that AXON’s stock grew somewhat faster than FGEN’s over the last 12 months.

AXON's Price Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for FGEN (93). This means that AXON’s stock grew significantly faster than FGEN’s over the last 12 months.

AXON's P/E Growth Rating (8) in the Biotechnology industry is somewhat better than the same rating for FGEN (56). This means that AXON’s stock grew somewhat faster than FGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONFGEN
RSI
ODDS (%)
Bearish Trend 4 days ago
53%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKSY21.481.21
+5.97%
BlackSky Technology Inc
HEPS2.800.06
+2.19%
D-Market Electronic Services & Trading
GPI466.001.38
+0.30%
Group 1 Automotive
KR69.83-0.40
-0.57%
Kroger Co (The)
GVH0.08-0.01
-7.80%
Globavend Holdings Limited

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+6.86%
AVTX - FGEN
57%
Loosely correlated
+0.40%
MGNX - FGEN
44%
Loosely correlated
+5.80%
AXON - FGEN
43%
Loosely correlated
+2.70%
BMRN - FGEN
41%
Loosely correlated
+0.58%
INSM - FGEN
39%
Loosely correlated
N/A
More